Properties
Description
Donitriptan inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets 5-HT1B receptor, and 5-HT1D receptor.
Molecular Formula
C23H25N5O2
Targets
5-HT1B receptor: 9.4 (pKi); 5-HT1D receptor: 9.3 (pKi)
Applications
Donitriptan can be used to research and develop therapeutic strategies for certain diseases that involve excessive activation of GPCR-G protein signaling pathways.